Draft Product List.xlsx

This is a draft product list for pharmaceutical compounding and delivery services. The document outlines over 140 line items spanning oncology drugs, biologics, and supportive care medications required for the VA Southern Nevada Health Care System's pharmacy hazardous compounding contingency contract. Products include chemotherapy agents (carboplatin, cisplatin, paclitaxel, docetaxel), monoclonal antibodies (bevacizumab, nivolumab, pembrolizumab, rituximab), targeted therapies (trastuzumab, pertuzumab), supportive medications (leucovorin, mesna, fosaprepitant), and infusion solutions (dextrose, sodium chloride, sterile water) in various dosage strengths. The list also includes facility patient fees for USP 797 and 800 compounding with delivery, intrathecal mixing services, and expedited STAT order fees.

The product list incorporates pricing structure options including discount types, receipt types (FOB Origin or FOB Destination), and geographic delivery specifications across all 50 states and U.S. territories. All items are marked as "Priced," indicating that vendors must provide pricing for the baseline requirement and multiple option years. The draft format indicates this pricing template is subject to change prior to formal solicitation, and vendors responding to the anticipated Request for Quote should be prepared to quote competitively on the complete pharmaceutical and compounding service portfolio listed.